144 related articles for article (PubMed ID: 32166120)
1. The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma.
Nomair AM; Issa NM; Madkour MA; Shamseya MM
Clin Exp Hepatol; 2020 Feb; 6(1):20-27. PubMed ID: 32166120
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma.
Wahb AMSE; El Kassas M; Khamis AK; Elhelbawy M; Elhelbawy N; Habieb MSE
World J Hepatol; 2021 Nov; 13(11):1753-1765. PubMed ID: 34904043
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
[TBL] [Abstract][Full Text] [Related]
6. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
8. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
10. Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.
Li J; Qiyu S; Wang T; Jin B; Li N
Open Life Sci; 2019 Jan; 14():53-61. PubMed ID: 33817137
[TBL] [Abstract][Full Text] [Related]
11. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
12. Value of Serum miRNA-96-5p and miRNA-99a-5p as Diagnostic Biomarkers for Hepatocellular Carcinoma.
Gharib AF; Eed EM; Khalifa AS; Raafat N; Shehab-Eldeen S; Alwakeel HR; Darwiesh E; Essa A
Int J Gen Med; 2022; 15():2427-2436. PubMed ID: 35264879
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients.
El-Ahwany EGE; Mourad L; Zoheiry MMK; Abu-Taleb H; Hassan M; Atta R; Hassanien M; Zada S
Arch Med Sci; 2019 Oct; 15(6):1454-1461. PubMed ID: 31749873
[TBL] [Abstract][Full Text] [Related]
14. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Elsewify WAE; Hassan EA; Mekky MA; Abd El-Rehim ASE; Sayed ZEA; Abdel Malek MO; ElMelegy TTH; Sabry A
Int J Gen Med; 2020; 13():147-155. PubMed ID: 32431531
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
[TBL] [Abstract][Full Text] [Related]
17. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
19. Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection.
Montaser LM; Abbas OM; Saltah AM; Waked IA
J Egypt Natl Canc Inst; 2007 Mar; 19(1):48-60. PubMed ID: 18839035
[TBL] [Abstract][Full Text] [Related]
20. Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma.
Eldeeb MK; Magour GM; Bedair RN; Shamseya MM; Hammouda MA
Clin Exp Hepatol; 2020 Jun; 6(2):85-91. PubMed ID: 32728624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
